Page last updated: 2024-08-21

chenodeoxycholic acid and Lassitude

chenodeoxycholic acid has been researched along with Lassitude in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
de Veer, RC; Laschtowitz, A; Schramm, C; Van der Meer, AJ1
Gershwin, ME; Hirschfield, GM; Lleo, A; Wang, GQ1
Andreone, P; Bowlus, CL; Drenth, JPH; Hirschfield, GM; MacConell, L; Malecha, ES; Nevens, F; Pencek, R; Shapiro, D; Shiffman, ML; Trauner, M; Vargas, V1

Reviews

2 review(s) available for chenodeoxycholic acid and Lassitude

ArticleYear
Diagnosis and treatment of primary biliary cholangitis.
    United European gastroenterology journal, 2020, Volume: 8, Issue:6

    Topics: Autoantigens; Autoimmune Diseases; Bezafibrate; Biomarkers; Biopsy; Chenodeoxycholic Acid; Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Elasticity Imaging Techniques; End Stage Liver Disease; Fatigue; Female; Humans; Immunoglobulin M; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Middle Aged; Off-Label Use; Prognosis; Pruritus; Quality of Life; Severity of Illness Index; Sjogren's Syndrome; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid

2020
Primary biliary cholangitis.
    Lancet (London, England), 2020, 12-12, Volume: 396, Issue:10266

    Topics: Autoimmune Diseases; Biomarkers; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Fatigue; Humans; Pruritus; Risk Factors; Ursodeoxycholic Acid

2020

Trials

1 trial(s) available for chenodeoxycholic acid and Lassitude

ArticleYear
Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study.
    The lancet. Gastroenterology & hepatology, 2019, Volume: 4, Issue:6

    Topics: Alkaline Phosphatase; Bilirubin; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Dose-Response Relationship, Drug; Double-Blind Method; Fatigue; Female; Gastrointestinal Agents; Humans; Male; Middle Aged; Pruritus; Ursodeoxycholic Acid

2019
chemdatabank.com